Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Aug;56(8):622–627. doi: 10.1136/thorax.56.8.622

Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests

J Dawson 1, H Fewins 1, J Desmond 1, M Lynch 1, D Graham 1
PMCID: PMC1746113  PMID: 11462065

Abstract

BACKGROUND—Fibrosing alveolitis (FA) is a common and serious complication of rheumatoid arthritis (RA). Before the availability of high resolution computed tomographic (HRCT) scanning, it was difficult to diagnose accurately without recourse to biopsy. Prospective studies have reported a prevalence of interstitial lung disease (ILD) of 19-44%. The term ILD used by these authors encompasses a variety of appearances on HRCT scans. This prospective study used HRCT scanning to determine the true prevalence of FA in hospital outpatients with RA, and to study associated clinical characteristics.
METHODS—One hundred and fifty consecutive patients with RA were selected from a hospital outpatient department, irrespective of the presence or absence of chest disease. All underwent a detailed clinical assessment, chest HRCT scanning, and conventional chest radiography within 4 weeks of full pulmonary function tests.
RESULTS—Seventy percent of patients were current or reformed cigarette smokers. Twenty eight (19%) had FA, most frequently of reticular pattern, and 12 of this group (43%) also had emphysematous bullae. None of the previously suggested risk factors for developing FA were confirmed. Fifty four percent of patients with HRCT evidence of FA had bilateral basal chest crackles, 82% had a reduced carbon monoxide transfer factor (TLCO), 14% had restrictive pulmonary function tests, and 14% had bilateral chest radiographic signs of FA.
CONCLUSIONS—HRCT evidence of FA was present in 19% of hospital outpatients with RA. Abnormalities on chest examination or on full pulmonary function tests, even without restrictive changes or chest radiographic abnormalities, should prompt physicians to request a chest HRCT scan when investigating dyspnoea in patients with RA.



Full Text

The Full Text of this article is available as a PDF (146.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Cervantes-Perez P., Toro-Perez A. H., Rodriguez-Jurado P. Pulmonary involvement in rheumatoid arthritis. JAMA. 1980 May 2;243(17):1715–1719. [PubMed] [Google Scholar]
  3. Cortet B., Perez T., Roux N., Flipo R. M., Duquesnoy B., Delcambre B., Rémy-Jardin M. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1997 Oct;56(10):596–600. doi: 10.1136/ard.56.10.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deleuran B. W., Chu C. Q., Field M., Brennan F. M., Mitchell T., Feldmann M., Maini R. N. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum. 1992 Oct;35(10):1170–1178. doi: 10.1002/art.1780351009. [DOI] [PubMed] [Google Scholar]
  5. Doherty M. J., Pearson M. G., O'Grady E. A., Pellegrini V., Calverley P. M. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax. 1997 Nov;52(11):998–1002. doi: 10.1136/thx.52.11.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. ELLMAN P., BALL R. E. Rheumatoid disease with joint and pulmonary manifestations. Br Med J. 1948 Nov 6;2(4583):816–820. doi: 10.1136/bmj.2.4583.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fewins H. E., McGowan I., Whitehouse G. H., Williams J., Mallya R. High definition computed tomography in rheumatoid arthritis associated pulmonary disease. Br J Rheumatol. 1991 Jun;30(3):214–216. doi: 10.1093/rheumatology/30.3.214. [DOI] [PubMed] [Google Scholar]
  8. Frank S. T., Weg J. G., Harkleroad L. E., Fitch R. F. Pulmonary dysfunction in rheumatoid disease. Chest. 1973 Jan;63(1):27–34. doi: 10.1378/chest.63.1.27. [DOI] [PubMed] [Google Scholar]
  9. Fujii M., Adachi S., Shimizu T., Hirota S., Sako M., Kono M. Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thorac Imaging. 1993 Winter;8(1):54–62. [PubMed] [Google Scholar]
  10. Gabbay E., Tarala R., Will R., Carroll G., Adler B., Cameron D., Lake F. R. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):528–535. doi: 10.1164/ajrccm.156.2.9609016. [DOI] [PubMed] [Google Scholar]
  11. Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest. 1988 Jan;93(1):114–118. doi: 10.1378/chest.93.1.114. [DOI] [PubMed] [Google Scholar]
  12. Hubbard R., Baoku Y., Kalsheker N., Britton J., Johnston I. Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study. Eur Respir J. 1997 Dec;10(12):2881–2883. doi: 10.1183/09031936.97.10122881. [DOI] [PubMed] [Google Scholar]
  13. Katzenstein A. L., Myers J. L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301–1315. doi: 10.1164/ajrccm.157.4.9707039. [DOI] [PubMed] [Google Scholar]
  14. Mathieson J. R., Mayo J. R., Staples C. A., Müller N. L. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989 Apr;171(1):111–116. doi: 10.1148/radiology.171.1.2928513. [DOI] [PubMed] [Google Scholar]
  15. McDonagh J., Greaves M., Wright A. R., Heycock C., Owen J. P., Kelly C. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol. 1994 Feb;33(2):118–122. doi: 10.1093/rheumatology/33.2.118. [DOI] [PubMed] [Google Scholar]
  16. Müller-Leisse C., Bussmann A., Meyer O., Vorbrüggen W., Genth E., Günther R. W. Lungenmanifestation bei rheumatoider Arthritis: hochauflösende Computertomographie in Wechselbeziehung zur Skelettmanifestation und zu laborchemischen Veränderungen. Rofo. 1996 Nov;165(5):438–444. doi: 10.1055/s-2007-1015786. [DOI] [PubMed] [Google Scholar]
  17. Okuda Y., Takasugi K., Imai A., Oyama T., Oyama H., Kawamura S. [Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT]. Ryumachi. 1993 Feb;33(1):12–19. [PubMed] [Google Scholar]
  18. Orens J. B., Kazerooni E. A., Martinez F. J., Curtis J. L., Gross B. H., Flint A., Lynch J. P., 3rd The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest. 1995 Jul;108(1):109–115. doi: 10.1378/chest.108.1.109. [DOI] [PubMed] [Google Scholar]
  19. Oxholm P., Madsen E. B., Manthorpe R., Rasmussen F. V. Pulmonary function in patients with rheumatoid arthritis. Scand J Rheumatol. 1982;11(2):109–112. doi: 10.3109/03009748209098172. [DOI] [PubMed] [Google Scholar]
  20. Padley S. P., Hansell D. M., Flower C. D., Jennings P. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol. 1991 Oct;44(4):222–226. doi: 10.1016/s0009-9260(05)80183-7. [DOI] [PubMed] [Google Scholar]
  21. Roschmann R. A., Rothenberg R. J. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum. 1987 Feb;16(3):174–185. doi: 10.1016/0049-0172(87)90020-5. [DOI] [PubMed] [Google Scholar]
  22. Saag K. G., Kolluri S., Koehnke R. K., Georgou T. A., Rachow J. W., Hunninghake G. W., Schwartz D. A. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996 Oct;39(10):1711–1719. doi: 10.1002/art.1780391014. [DOI] [PubMed] [Google Scholar]
  23. Sasaka K., Nakajima Y., Kase C., Yamada H. [Plain film and CT findings of pulmonary involvement in rheumatoid arthritis]. Ryumachi. 1998 Oct;38(5):705–716. [PubMed] [Google Scholar]
  24. Schernthaner G., Scherak O., Kolarz G., Kummer F. Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung. Ann Rheum Dis. 1976 Jun;35(3):258–262. doi: 10.1136/ard.35.3.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stephens K. E., Ishizaka A., Larrick J. W., Raffin T. A. Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respir Dis. 1988 Jun;137(6):1364–1370. doi: 10.1164/ajrccm/137.6.1364. [DOI] [PubMed] [Google Scholar]
  26. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wells A. U., Rubens M. B., du Bois R. M., Hansell D. M. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR Am J Roentgenol. 1993 Dec;161(6):1159–1165. doi: 10.2214/ajr.161.6.8249719. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES